phosphate

Disodium Hydrogen Phosphate (CAS 7558-79-4) Disodium hydrogen phosphate is commonly used in conjunction with trisodium phosphate for applications in food processing and water treatment systems. Product Specifications Product Name: Disodium Hydrogen Phosphate CAS No.: 7558-79-4 Assay: 98% Molecular Formula: HO4P.2Na Molecular Weight: 141.96 Shelf Life: 2 Years Package: 25kg/drum Product Documentation & Images

Sodium Dihydrogen Phosphate (89140-32-9) Sodium dihydrogen phosphate serves as a versatile additive with applications across multiple industries. It is commonly used to regulate acidity and provide antioxidant properties in food and pharmaceutical products. Product Specifications Product Name: Sodium Dihydrogen Phosphate CAS No.: 89140-32-9 Assay: 98% Molecular Formula: HOPNa Molecular Weight: 119.98 Shelf Life: 2 Years Package: 25kg/drum Product Images

Baricitinib Phosphate (1187595-84-1) Baricitinib is a selective JAK1 and JAK2 inhibitor that has shown promising results as a treatment for rheumatoid arthritis and other inflammatory conditions. Product Name Baricitinib Phosphate CAS No. 1187595-84-1 Assay 98% Specification CP, EP, In-house, as required Molecular Formula C16 H20 N7 O6 PS Molecular Weight 469.41 Shelf Life 2 Years Package 25kg/drum

Dexamethasone Sodium Phosphate (312-93-6) A prodrug of Dexamethasone, this anti-inflammatory glucocorticoid demonstrates enhanced therapeutic efficacy. Research shows that liposomal DXM-P effectively inhibits both chronic inflammation and joint destruction, whereas free DXM-P fails to prevent joint destruction. Product Specifications Product Name: Dexamethasone Sodium Phosphate CAS No.: 312-93-6 Assay: 99% Specification: CP, EP, In-house, as required Molecular Formula: CH

Ruxolitinib Phosphate (1092939-17-7) Ruxolitinib is an anti-tumor pharmaceutical agent indicated for the treatment of myeloproliferative neoplasm-associated myelofibrosis, polycythemia vera, and other myeloproliferative neoplasms, as well as refractory cancers. Product Specifications Product Name: Ruxolitinib Phosphate CAS No.: 1092939-17-7 Assay: 98% Specification: CP, EP, In-house, as required Molecular Formula: C17 H21 N6 O4 P Molecular Weight: 404.36 Shelf Life: 2 Years

3-Cyclopentylacrylonitrile (591769-05-0) 3-Cyclopentylacrylonitrile and its derivatives serve as key intermediates in the synthesis of pharmaceutical compounds including ruxolitinib intermediates and trasitinib phosphate. Product Specifications Product Name: 3-cyclopentylacrylonitrile CAS No.: 591769-05-0 Assay: 98% Molecular Formula: C9H12 Molecular Weight: 120.19 Shelf Life: 2 Years Package: 25kg/drum Product Images

Etrasimod (1206123-37-6) Etrasimod is a novel oral, selective sphingosine 1-phosphate (S1P) receptor modulator indicated for the treatment of adult patients with moderately to severely active ulcerative colitis. It functions by partially and reversibly blocking lymphocyte outflow, reducing peripheral blood lymphocyte counts, thereby limiting lymphocyte migration to the intestines and delivering therapeutic benefits. Product Specifications Product Name: Etrasimod CAS No.:

3-Cyano-4-isopropoxybenzoic Acid (258273-31-3) 3-Cyano-4-isopropoxybenzoic Acid is a valuable chemical reagent used in the synthesis of cyanoaryloxadiazolyl-substituted nitrogen heterocycles. These compounds function as S1P3-sparing agonists of sphingosine phosphate receptors S1P1 and S1P5, with applications in the treatment of multiple sclerosis. The compound is also utilized in studies involving the preparation and structure-activity relationship (SAR) of biaryl oxadiazoles

Sodium 8-(2-hydroxybenzamido) Octanoate (SNAC) - CAS 203787-91-1 Salcaprozate sodium (SNAC) is the sodium salt form of salcaprozate, specifically developed for the treatment of gastrointestinal disorders, particularly those caused by malabsorption of dicarbonate-phosphate compounds. SNAC enhances drug absorption in gastrointestinal epithelial cells and effectively overcomes absorption barriers for oral peptide drugs such as Semaglutide. Product Name: Sodium 8-(2-hydroxybenzam